|
|
Christian W. Schindler
J Clin Invest. 2002;
109(9):1133
doi:10.1172/JCI15644
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(20)
| Title and authors |
Publication |
Year |
PDGF-β receptor and PKC have no effect on angiotensin II-induced JAK2 and STAT1 phosphorylation in vascular smooth muscle cells under high glucose condition
Oktay Hasan Öztürk, Arzu Çetin, Alper Tokay, Fatih Uzuner, Gamze Tanrıöver, Akın Yeşilkaya
|
Journal of Receptors and Signal Transduction
|
2011 |
Exome sequencing identifies a missense mutation in Isl1 associated with low penetrance otitis media in dearisch mice
Jennifer M Hilton, Morag A Lewis, M'hamed Grati, Neil Ingham, Selina Pearson, Roman A Laskowski, David J Adams, Karen P Steel
|
Genome Biol.
|
2011 |
Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling.
Yrina Rochman, Mohit Kashyap, Gertraud W Robinson, Kazuhito Sakamoto, Julio Gomez-Rodriguez, Kay-Uwe Wagner, Warren J Leonard
|
Proc. Natl. Acad. Sci. U.S.A.
|
2010 |
CrossRef Listing of Deleted DOIs
|
CrossRef Listing of Deleted DOIs
|
2008 |
Model-based analysis of interferon-beta induced signaling pathway.
Jaroslaw Smieja, Mohammad Jamaluddin, Allan R Brasier, Marek Kimmel
|
Bioinformatics
|
2008 |
A Role for PPARgamma in the Regulation of Cytokines in Immune Cells and Cancer.
Xiao Yi Yang, Li Hua Wang, William L Farrar
|
PPAR Research
|
2008 |
Mutations in JAK2V617F homologous domain of JAK genes are uncommon in solid tumors
Nelly Motté, Patrick Saulnier, Jean-Pierre Le Couedic, Jean-Charles Soria, Suzette Delaloge, Valérie Boige, Patricia Pautier, William Vainchenker, Jean-Michel Bidart, Jean-Luc Villeval
|
Int. J. Cancer
|
2007 |
A potential role for HSP90 inhibitors in the treatment of JAK2 mutant-positive diseases as demonstrated using quantitative flow cytometry
Joanne Bareng, Iman Jilani, Mercedes Gorre, Hagop Kantarjian, Francis J. Giles, Alison Hannah, Maher Albitar
|
Leuk Lymphoma
|
2007 |
JAK2 V617F in myeloid disorders: What do we know now, and where are we headed?
Maria E. Nelson, David P. Steensma
|
Leuk Lymphoma
|
2006 |
Activation of STAT3 in thymic epithelial tumours correlates with tumour type and clinical behaviour
K-C Chang, M-H Wu, D Jones, F-F Chen, Y-L Tseng
|
J. Pathol.
|
2006 |
|
